TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Orion Pharma AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
1,000,300
|
917,048
|
832,131 |
| Financial expenses |
30
|
9
|
2 |
| Earnings before taxes |
45,519
|
39,700
|
35,042 |
| EBITDA |
42,914
|
38,090
|
34,680 |
| Total assets |
254,334
|
214,920
|
282,286 |
| Current assets |
251,080
|
211,590
|
278,729 |
| Current liabilities |
81,092
|
40,304
|
123,410 |
| Equity capital |
169,871
|
171,526
|
155,860 |
| - share capital |
100
|
100
|
100 |
| Employees (average) |
51
|
49
|
48 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
66.8%
|
79.8%
|
55.2% |
| Turnover per employee |
19,614
|
18,715
|
17,336 |
| Profit as a percentage of turnover |
4.6%
|
4.3%
|
4.2% |
| Return on assets (ROA) |
17.9%
|
18.5%
|
12.4% |
| Current ratio |
309.6%
|
525.0%
|
225.9% |
| Return on equity (ROE) |
26.8%
|
23.1%
|
22.5% |
| Change turnover |
83,252
|
84,917
|
23,753 |
| Change turnover % |
9%
|
10%
|
3% |
| Chg. No. of employees |
2
|
1
|
0 |
| Chg. No. of employees % |
4%
|
2%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.